1. Home
  2. UVE vs AVXL Comparison

UVE vs AVXL Comparison

Compare UVE & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UVE
  • AVXL
  • Stock Information
  • Founded
  • UVE 1990
  • AVXL 2004
  • Country
  • UVE United States
  • AVXL United States
  • Employees
  • UVE N/A
  • AVXL N/A
  • Industry
  • UVE Property-Casualty Insurers
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • UVE Finance
  • AVXL Health Care
  • Exchange
  • UVE Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • UVE 642.7M
  • AVXL 750.3M
  • IPO Year
  • UVE 1992
  • AVXL N/A
  • Fundamental
  • Price
  • UVE $23.39
  • AVXL $9.44
  • Analyst Decision
  • UVE
  • AVXL Strong Buy
  • Analyst Count
  • UVE 0
  • AVXL 2
  • Target Price
  • UVE N/A
  • AVXL $44.00
  • AVG Volume (30 Days)
  • UVE 171.2K
  • AVXL 1.2M
  • Earning Date
  • UVE 04-24-2025
  • AVXL 05-08-2025
  • Dividend Yield
  • UVE 2.74%
  • AVXL N/A
  • EPS Growth
  • UVE N/A
  • AVXL N/A
  • EPS
  • UVE 2.01
  • AVXL N/A
  • Revenue
  • UVE $1,520,536,000.00
  • AVXL N/A
  • Revenue This Year
  • UVE N/A
  • AVXL N/A
  • Revenue Next Year
  • UVE $3.77
  • AVXL N/A
  • P/E Ratio
  • UVE $11.30
  • AVXL N/A
  • Revenue Growth
  • UVE 9.27
  • AVXL N/A
  • 52 Week Low
  • UVE $16.50
  • AVXL $3.25
  • 52 Week High
  • UVE $24.14
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • UVE 60.47
  • AVXL 59.75
  • Support Level
  • UVE $22.42
  • AVXL $8.61
  • Resistance Level
  • UVE $23.32
  • AVXL $9.17
  • Average True Range (ATR)
  • UVE 0.81
  • AVXL 0.65
  • MACD
  • UVE 0.04
  • AVXL 0.11
  • Stochastic Oscillator
  • UVE 84.89
  • AVXL 97.59

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums. It operates within Florida and across the United States. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: